| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/28/1994 | US5324504 Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI |
| 06/28/1994 | US5324503 Iodo-phenylated chelates for x-ray contrast |
| 06/28/1994 | US5323780 For magnetic resonance imaging of a sample |
| 06/23/1994 | WO1994013327A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/23/1994 | WO1994013311A1 Glycolipid enzyme-polymer conjugates |
| 06/23/1994 | CA2151614A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/23/1994 | CA2150956A1 Glycolipid enzyme-polymer conjugates |
| 06/22/1994 | EP0603160A2 Compositions for in-situ active compound assembly |
| 06/22/1994 | EP0602970A2 A measuring method using resonance of a resonance body |
| 06/22/1994 | EP0602702A1 The use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 06/22/1994 | EP0602700A2 Novel formulations for nanoparticulate X-ray blood pool contrast agents using high molecular weight surfactants |
| 06/22/1994 | EP0602691A2 Controlled precipitation of particulate diagnostic imaging contrast agents |
| 06/22/1994 | EP0602543A1 Layered carrier for the diagnosis and therapy of sicknesses and use thereof |
| 06/22/1994 | CN1088210A Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 06/22/1994 | CN1088114A Improvements in or relating to contrast agents |
| 06/21/1994 | US5322934 Passing through cation permeable membrane and anion permeable membrane |
| 06/21/1994 | US5322838 Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation |
| 06/21/1994 | US5322681 Chelating compounds |
| 06/21/1994 | US5322679 Contrast agent for x-ray images |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/21/1994 | US5322065 Stable free radical containing contrast media |
| 06/21/1994 | US5322063 Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| 06/21/1994 | CA1330302C Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| 06/18/1994 | CA2107695A1 Water insoluble manganese particles as magnetic resonance contrast enhancement agents |
| 06/18/1994 | CA2107165A1 Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants |
| 06/17/1994 | CA2108061A1 Iodinated wetting agents |
| 06/17/1994 | CA2106413A1 Iodinated aroyloxy esters |
| 06/17/1994 | CA2102356A1 Use of purified surface modifiers to prevent particle aggregation during sterilization |
| 06/16/1994 | CA2107164A1 Controlled precipitation of particulate diagnostic imaging contrast agents |
| 06/15/1994 | EP0601619A2 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/15/1994 | EP0601618A2 Use of charged phospholipids for decreasing nanoparticulate aggregation |
| 06/15/1994 | EP0601617A1 Iodinated benzoyl acetals and ketals, and contrast agents containing them |
| 06/15/1994 | EP0601616A1 Iodinated aroyloxy carboxamides and contrast agents containing them |
| 06/15/1994 | EP0601417A2 Physiologically compatible and degradable polymer-based carbohydrate receptor blockers, a method for their preparation and their use |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0600869A1 Synthetic peptides for arterial imaging |
| 06/15/1994 | CA2102269A1 Iodinated aromatic compounds |
| 06/14/1994 | US5321008 Administering an insulin and a calcitonin |
| 06/14/1994 | US5320906 Delivery vehicles with amphiphile-associated active ingredient |
| 06/14/1994 | US5320826 Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
| 06/12/1994 | CA2111129A1 Physiologically tolerated and physiologically degradable polymer-based carbohydrate receptor blocker, a process for its preparation and its use |
| 06/12/1994 | CA2102267A1 Use of charged phospholipids to reduce nanoparticle aggregation |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012627A1 Transgenic animal model for alzheimer's disease |
| 06/09/1994 | WO1994012105A1 Contact medium for probe of ultrasonic diagnostic apparatus |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2107597A1 Iodinated aroyloxy carboxamides |
| 06/08/1994 | EP0600532A2 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 06/08/1994 | EP0600529A2 Preparation and magnetic properties of very small magnetite-dextran particles |
| 06/08/1994 | EP0600528A1 Method of grinding pharmaceutical substances |
| 06/08/1994 | EP0599979A1 LABELLED $g(b)-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 06/08/1994 | EP0599946A1 Fullerene compositions for magnetic resonance spectroscopy and imaging |
| 06/08/1994 | EP0599839A1 Method of mri imaging using diamagnetic contrast agents |
| 06/08/1994 | EP0470188B1 Novel magnetic resonance imaging agents |
| 06/07/1994 | US5319105 Derivatives and anologs of monoethylglycinexylidide |
| 06/07/1994 | US5319059 Polyurethane covalently bonded to glycerol monoesters of diatrizoic acid and triiodobenzoic acid derivatives; biocompatible and biodegradable |
| 06/07/1994 | US5318797 Coated particles, hollow particles, and process for manufacturing the same |
| 06/07/1994 | US5318771 Contrast agents |
| 06/07/1994 | US5318770 Trifluoromethyl analogs of X-ray contrast media for magnetic resonance imaging |
| 06/07/1994 | US5318769 Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract |
| 06/07/1994 | US5318768 For gastrointestinal tract; film membrane, cation potentiator, particle surface modifier |
| 06/07/1994 | US5318767 X-ray contrast compositions useful in medical imaging |
| 06/05/1994 | CA2107723A1 Iodinated benzoyl acetals and ketals |
| 06/05/1994 | CA2107694A1 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/05/1994 | CA2102551A1 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 06/03/1994 | CA2107280A1 Preparation and magnetic properties of very small magnetite-dextran particles |
| 06/01/1994 | EP0598837A1 Amino acid, ester and/or catechol contrast agents for mri |
| 06/01/1994 | EP0598751A1 Synthesis of ioversol using chloroacetyl chloride |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316771 Method of amphiphatic drug loading in liposomes by ammonium ion gradient |
| 05/31/1994 | US5316757 MRI contrast agent |
| 05/31/1994 | US5316756 NMR imaging using paramagnetic chelates having hydroxyalkyl-substituted amide groups |
| 05/31/1994 | US5316755 Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract |
| 05/31/1994 | US5315998 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
| 05/31/1994 | US5315997 Method of magnetic resonance imaging using diamagnetic contrast |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011348A1 Detection of hypoxia |
| 05/26/1994 | WO1994011033A1 Granular preparation for mri |
| 05/26/1994 | WO1994008624A3 Therapeutic and diagnostic imaging compositions and methods |
| 05/26/1994 | WO1993025243A3 Metal complexes formed with macrocyclic ligands for use in imaging techniques |
| 05/26/1994 | DE4239213A1 Medical swab - comprises muslin layers folded in on themselves and having sealed edges to prevent fibre detachment |
| 05/26/1994 | CA2149343A1 Granular preparation for mri |
| 05/25/1994 | EP0597865A1 Heavy metal clusters for use as imaging agents |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0434833B1 9-fluor-prostaglandine derivates, their process of production and their pharmaceutical use |
| 05/25/1994 | CN1087016A Process for preparing medical ultrasonic coupling agent |
| 05/25/1994 | CN1024628C Developer containing edible plant for ultrasonic examination |
| 05/24/1994 | US5315035 Aniline derivatives useful as color formers |
| 05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
| 05/24/1994 | US5314695 Tissue factor based prothrombin time reagent |
| 05/24/1994 | US5314680 Polyazamacrocycles for magnetic resonance imaging |
| 05/24/1994 | US5314679 Metal oxides |
| 05/19/1994 | DE4238416A1 Bestimmung von Peptidmotiven auf MHC-Molekülen Determination of peptide motifs on MHC molecules |
| 05/18/1994 | EP0597699A2 Protein secreted by cancer cells |
| 05/18/1994 | EP0596984A1 Preparation of microparticles |
| 05/17/1994 | US5312617 Liposoluble compounds useful as magnetic resonance imaging agents |
| 05/17/1994 | US5312616 Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
| 05/17/1994 | US5312615 Encapsulation, extrusion and filtration of liposomes |